Trial Profile
Postoperative Concurrent Chemoradiotherapy Combined With Recombinant Human Endostatin for High-risk Early Stage Cervical Cancer: A Phase II Pilot Study (ChESS).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2018
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Endostatin (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ChESS
- 20 Aug 2018 New trial record